You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

ACETIC ACID, GLACIAL; HYDROCORTISONE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


Summary for ACETIC ACID, GLACIAL; HYDROCORTISONE
Pharmacology for ACETIC ACID, GLACIAL; HYDROCORTISONE
Anatomical Therapeutic Chemical (ATC) Classes for ACETIC ACID, GLACIAL; HYDROCORTISONE
A01AC Corticosteroids for local oral treatment
A01A STOMATOLOGICAL PREPARATIONS
A01 STOMATOLOGICAL PREPARATIONS
A Alimentary tract and metabolism
A07EA Corticosteroids acting locally
A07E INTESTINAL ANTIINFLAMMATORY AGENTS
A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
A Alimentary tract and metabolism
C05AA Corticosteroids
C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
C05 VASOPROTECTIVES
C Cardiovascular system
D07AA Corticosteroids, weak (group I)
D07A CORTICOSTEROIDS, PLAIN
D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
D Dermatologicals
D07XA Corticosteroids, weak, other combinations
D07X CORTICOSTEROIDS, OTHER COMBINATIONS
D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
D Dermatologicals
G01AD Organic acids
G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
G Genito-urinary system and sex hormones
H02AB Glucocorticoids
H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
H02 CORTICOSTEROIDS FOR SYSTEMIC USE
H Systemic hormonal preparations, excluding sex hormones and insulins
S01BA Corticosteroids, plain
S01B ANTIINFLAMMATORY AGENTS
S01 OPHTHALMOLOGICALS
S Sensory organs
S01CB Corticosteroids/antiinfectives/mydriatics in combination
S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION
S01 OPHTHALMOLOGICALS
S Sensory organs
S02AA Antiinfectives
S02A ANTIINFECTIVES
S02 OTOLOGICALS
S Sensory organs
S02BA Corticosteroids
S02B CORTICOSTEROIDS
S02 OTOLOGICALS
S Sensory organs

US Patents and Regulatory Information for ACETIC ACID, GLACIAL; HYDROCORTISONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cosette HYDROCORTISONE AND ACETIC ACID acetic acid, glacial; hydrocortisone SOLUTION/DROPS;OTIC 040609-001 Feb 6, 2006 AT RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Taro HYDROCORTISONE AND ACETIC ACID acetic acid, glacial; hydrocortisone SOLUTION/DROPS;OTIC 088759-001 Mar 4, 1985 AT RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Actavis Mid Atlantic ACETASOL HC acetic acid, glacial; hydrocortisone SOLUTION/DROPS;OTIC 087143-001 Jan 13, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

ACETIC ACID, GLACIAL; HYDROCORTISONE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Acetic Acid, Glacial, and Hydrocortisone

Introduction

The markets for glacial acetic acid and hydrocortisone are driven by diverse factors, including industrial demand, healthcare needs, and environmental considerations. Here, we delve into the market dynamics, growth trends, and financial trajectories of these two chemicals.

Glacial Acetic Acid Market Dynamics

Market Size and Growth

The global glacial acetic acid market is projected to experience significant growth. By 2028, the market size is expected to reach 2,081.48 kilotons, growing at a CAGR of 3.85% from 2023[1]. In terms of value, the market is estimated to reach USD 8,801.6 million in 2024 and is projected to grow at a CAGR of 6.5% to reach USD 16,521.8 million by 2034[4].

Segmentation

The glacial acetic acid market is segmented by grade (food, industrial, and pharmaceutical) and application. The industrial segment is a major driver due to its use in manufacturing purified terephthalic acid (PTA) for textiles and packaging[4].

Key Drivers

  • Industrial Demand: The consistent growth of the chemical sector, particularly in the Asia Pacific region, fuels the demand for glacial acetic acid.
  • Sustainability: The potential of glacial acetic acid as a sustainable solvent and its use in bioplastics are emerging trends.
  • Regulatory Environment: Stringent environmental laws and incentives for bio-based acetic acid production support market growth[4].

Challenges

  • Supply Chain Disruptions: The COVID-19 pandemic caused temporary disruptions in supply chains, affecting demand. However, demand rebounded post-pandemic[1][4].
  • Price Volatility: Factors such as raw material costs, inventory levels, and geopolitical considerations can affect the price of glacial acetic acid[4].

Hydrocortisone Market Dynamics

Market Size and Growth

The hydrocortisone market is also experiencing robust growth. The global hydrocortisone market size is expected to grow from $1.43 billion in 2023 to $1.96 billion by 2028 at a CAGR of 6.6%[2].

Segmentation

The hydrocortisone market is segmented into various forms, including creams, ointments, and ear drops. The hydrocortisone cream market, specifically, is projected to reach USD 2,101.3 million by 2031, growing at a CAGR of 6.50% from 2024 to 2031[5].

Key Drivers

  • Healthcare Demand: Rising skin disorder prevalence, an aging population, and increased awareness drive the demand for hydrocortisone products.
  • Technological Advancements: Innovations such as combination therapies, personalized treatments, and hydrocortisone-infused products contribute to market growth.
  • OTC Demand: The surge in over-the-counter (OTC) demand and expanded distribution channels also boost the market[2][5].

Regional Trends

  • North America: Dominates the hydrocortisone cream market with a significant market share, driven by sophisticated healthcare infrastructure and high prevalence of skin conditions[5].
  • Asia-Pacific: Expected to experience the highest CAGR due to increasing healthcare expenditure and growing consumer awareness of skin health in countries like China and India[5].

Financial Trajectory

Glacial Acetic Acid

The financial trajectory for glacial acetic acid is marked by steady growth driven by industrial and pharmaceutical applications. Here are some key financial metrics:

  • Market Value: Expected to reach USD 8,801.6 million in 2024 and USD 16,521.8 million by 2034[4].
  • CAGR: 6.5% from 2024 to 2034[4].

Hydrocortisone

The hydrocortisone market is financially robust, with significant growth anticipated:

  • Market Value: Expected to grow from $1.43 billion in 2023 to $1.96 billion by 2028[2].
  • CAGR: 6.6% from 2023 to 2028[2].
  • Hydrocortisone Cream Market: Projected to reach USD 2,101.3 million by 2031, growing at a CAGR of 6.50% from 2024 to 2031[5].

Impact of COVID-19

Both markets experienced disruptions during the COVID-19 pandemic:

  • Glacial Acetic Acid: Demand plummeted due to global industrial shutdowns and supply chain disruptions. However, demand rebounded quickly as restrictions eased[1][4].
  • Hydrocortisone: The pandemic saw increased demand in the pharmaceutical sector, particularly for hydrocortisone, due to its use in treating various health conditions[2][4].

Sustainability and Regulatory Environment

Glacial Acetic Acid

  • Companies are investing in research and development to use novel and environmentally friendly feedstock, reducing the environmental footprint[4].
  • Governments are implementing stringent environmental laws and offering incentives for bio-based acetic acid production[4].

Hydrocortisone

  • The focus on sustainability is less pronounced but still relevant, with trends towards natural ingredients and sustainable practices in the broader healthcare sector[2].

Emerging Trends and Applications

Glacial Acetic Acid

  • Bioplastics: The use of acetic acid in bioplastics is an emerging trend, driven by environmental regulations and consumer demand for sustainable products[4].
  • Pharmaceuticals and Electronics: High-purity glacial acetic acids are in increasing demand in the pharmaceutical and electronics sectors[4].

Hydrocortisone

  • Combination Therapies: Innovations in combination therapies and personalized treatments are driving growth in the hydrocortisone market[2].
  • Hydrocortisone-Infused Products: The development of hydrocortisone-infused products is another significant trend[2].

Key Takeaways

  • The glacial acetic acid market is driven by industrial demand, sustainability trends, and regulatory environments.
  • The hydrocortisone market is fueled by healthcare needs, technological advancements, and OTC demand.
  • Both markets experienced disruptions during the COVID-19 pandemic but have since rebounded.
  • Sustainability and regulatory compliance are key factors influencing the growth of both markets.

FAQs

Q: What is the projected market size for glacial acetic acid by 2034?

The global glacial acetic acid market is projected to reach USD 16,521.8 million by 2034[4].

Q: What drives the demand for hydrocortisone?

Rising skin disorder prevalence, an aging population, increased awareness, and technological advancements drive the demand for hydrocortisone[2].

Q: How did the COVID-19 pandemic affect the glacial acetic acid market?

The pandemic caused temporary disruptions in supply chains and reduced demand, but demand rebounded quickly as restrictions eased[1][4].

Q: What are the emerging trends in the hydrocortisone market?

Emerging trends include combination therapies, personalized treatments, and the development of hydrocortisone-infused products[2].

Q: What is the significance of sustainability in the glacial acetic acid market?

Sustainability is crucial as companies invest in environmentally friendly feedstock and governments implement stringent environmental laws and offer incentives for bio-based acetic acid production[4].

Sources

  1. Mordor Intelligence: Glacial Acetic Acid Market - Growth Trends & Major Manufacturers.
  2. The Business Research Company: Global Hydrocortisone Market Report 2024.
  3. Mayo Clinic: Hydrocortisone and acetic acid (otic route).
  4. Future Market Insights: Glacial Acetic Acid Market Size, Growth & Trends by 2034.
  5. Cognitive Market Research: Hydrocortisone Cream Market Report 2024 (Global Edition).

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.